Cargando…

Efficacy of MAP0004 in treating severe migraine

Detalles Bibliográficos
Autores principales:	Kori, S, Connors, E, Zhou, J, Lu, B, Borland, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620254/ http://dx.doi.org/10.1186/1129-2377-1-S14-P208

Ejemplares similares

Analysis of subjects with menstrually related migraine vs. Non-menstrually related migraine treated with MAP0004
por: Aurora, S, et al.
Publicado: (2013)

MAP0004 provided consistent migraine pain relief even after repeated administration
por: Kori, S, et al.
Publicado: (2013)

Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
por: Kori, S, et al.
Publicado: (2013)

Adding acute treatments for patients on triptans: Results of the American Migraine Prevalence & Prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

Migraine without aura: genome-wide association analysis identifies several novel susceptibility
por: De Vries, B Loci, et al.
Publicado: (2013)

Application and efficacy of levetiracetam in prophylactic treatment of migraine without aura
por: Maykova, TN
Publicado: (2013)

Evaluation of vestibular evoked myogenic potentials in migraine and migrainous vertigo patients
por: ÇatýkerÜtkür, B, et al.
Publicado: (2013)

Migraine attacks during menses: efficacy of eletriptan and relationship to recurrence after response
por: Bhambri, Almas, et al.
Publicado: (2013)

Is ischemic stroke more severe in patients with migraine vs. other headache types?
por: Maticiuc, V, et al.
Publicado: (2013)

Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%
por: Gross, Ronald L, et al.
Publicado: (2007)

Survey of the differences between Migraine and MOH pre-existing migraine
por: Igarashi, H
Publicado: (2013)

Migraine without aura: genome-wide association analysis identifies several novel susceptibility
por: de Vries, Boukje, et al.
Publicado: (2013)

The borderline between cluster headache and migraine: does cluster-migraine exist?
por: Lisotto, C, et al.
Publicado: (2013)

Imaging the premonitory phase of migraine - new insights into generation of the migraine attack
por: Maniyar, FH, et al.
Publicado: (2013)

Migraine management in pregnancy
por: Jalilian, Nasrin, et al.
Publicado: (2012)

Relationship between migraine and malocclusion
por: Takeuchi, M, et al.
Publicado: (2013)

Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura
por: Antonova, M, et al.
Publicado: (2013)

The clincal characteristics of abdominal migraine and risk factors for developing migraine later in childhood
por: Lee, KH, et al.
Publicado: (2013)

Multimodal evoked potentials in chronic migraine
por: Coppola, G, et al.
Publicado: (2013)

Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

Characterization of a novel model for chronic migraine
por: Pradhan, A, et al.
Publicado: (2013)

Changes in glutamatergic neurotransmission within the migraine cycle
por: Cosentino, G, et al.
Publicado: (2013)

Chronic migraine is not associated with cerebellar infarct-like lesions
por: Meilan, A, et al.
Publicado: (2013)

The comorbidity between migraine and hypothyroidism
por: Lisotto, C, et al.
Publicado: (2013)

P014. Migraine and hypnosis
por: Ardore, Marco, et al.
Publicado: (2015)

Rv0004 is a new essential member of the mycobacterial DNA replication machinery
por: Mann, Katherine M., et al.
Publicado: (2017)

Major life events, stress appraisal, and migraine: results of the American Migraine Prevalence and Prevention (AMPP) study
por: Manack, AN, et al.
Publicado: (2013)

P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients
por: Iannacchero, Rosario, et al.
Publicado: (2015)

An open-label trial of alsuma auto-injector for migraine
por: Ramos, E, et al.
Publicado: (2013)

Developmental coordination disorder and migraine in childhood
por: Esposito, M, et al.
Publicado: (2013)

Nutraceutical preparations in childhood migraine prophylaxis
por: Carotenuto, M, et al.
Publicado: (2013)

Prostaglandins and prostaglandin receptor antagonism in migraine
por: Antonova, M
Publicado: (2013)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
por: Aurora, SK, et al.
Publicado: (2013)

Review of 500 migraine cases treated with combination of antidepressant & CBT & specific group of dietary supplement with 6 month follow up
por: Goyal, VK
Publicado: (2013)

Unraveling migraine susceptibility in females: the involvement of GABA genes
por: Quintas, MS, et al.
Publicado: (2013)

Provocation of migraine with aura using natural trigger factors
por: Hougaard, A, et al.
Publicado: (2013)

Headache, migraine, brain lesion and MRI study
por: Radojkovic Gligic, N, et al.
Publicado: (2013)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

P050. Migrainous aura: when to worry?
por: Fuccaro, Matteo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_323qe0vi87j27gc2v414fbvnc1